Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 190 Breast 110 Thoracic 41 Genitourinary 37 Gynecologic 33 Head & Neck 27 Sarcoma 26 CNS 20 Tumor-Agnostic 8 Lymphoid 7 Plasma cell 6 Other solid neoplasm 4 Dermatologic 3 Other hematologic neoplasm 2 Endocrine 1 Classical hematology 1

Conditions

Interventions

Cyclophosphamide 94 fludarabine phosphate 87 Busulfan 64 Cyclosporine 57 Epoetin Alfa 55 Peripheral Blood Stem Cell Transplantation 54 Mycophenolic Acid 54 Whole-Body Irradiation 53 fludarabine 45 Antilymphocyte Serum 43 Filgrastim 41 Cytarabine 41 Melphalan 40 Tacrolimus 39 Darbepoetin alfa 39 Methotrexate 34 Radiotherapy 33 Cord Blood Stem Cell Transplantation 28 Granulocyte Colony-Stimulating Factor 23 apixaban 22 Methylprednisolone 22 Rivaroxaban 21 Etoposide 21 Thiotepa 17 Dalteparin 17 eltrombopag 16 ferric carboxymaltose 14 epoetin beta 14 Daunorubicin 14 Azacitidine 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Therapy × Classical hematology × Clear all

NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡